Press release
Uveitis Treatment Market will Represent a Value of US$ 822.5 Mn by 2020
Globally, the uveitis treatment market is witnessing significant growth due to increasing prevalence of uveitis and related complications, and increasing aging population. Moreover, increasing R&D investments in drug discovery and development, and growing government initiatives to reduce eye disorders are also driving the growth of the market. However, lack of awareness about eye disorders, poor primary healthcare infrastructure, and lack of health insurance in developing countries are inhibiting the growth of the uveitis treatment market. The global uveitis treatment market is anticipated to grow from an estimated USD 539.0 million in 2014 to USD 822.5 million by 2020 at a CAGR of 7.3% during the forecast period.
Request Sample Report @ https://www.persistencemarketresearch.com/samples/4430
In North America, rising incidence of uveitis and related disorders, increasing aging population, and growing R&D investments by drug manufacturing companies for the development of innovative products to treat the disease in the region are driving the uveitis treatment options such as corticosteroids in the market. For instance, in North America, approximately 500,000 people are affected by uveitis every year; out of these, approximately 50,000 new blind cases occur due to uveitis, which accounts for approximately 10% of the overall blind cases in the region.
In Europe, the uveitis treatment market is driven by rising number of autoimmune disorders such as AIDS and multiple sclerosis. Moreover, in Germany, the market is evolving due to rising aging population and increasing the prevalence of eye disorders. However, in Asia, the growth for uveitis treatment is higher than that in developed regions, due to increasing prevalence of uveitis and growing aging population.
Request to View TOC @ https://www.persistencemarketresearch.com/methodology/4430
pSivida Corp., XOMA Corporation, Alcon, Inc., Allergan, Inc., AbbVie Inc., Enzo Biochem Inc., OphthaliX Inc., Bausch & Lomb Incorporated, Regeneron Pharmaceuticals, Inc, and Santen Pharmaceutical Co., Ltd. are some of the major players in the uveitis treatment market.
ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Uveitis Treatment Market will Represent a Value of US$ 822.5 Mn by 2020 here
News-ID: 1086402 • Views: …
More Releases from Persistence Market Research
Refined Glycerin Market to Reach US$ 6.1 Bn by 2032 Driven by Expanding Applicat …
➤ Overview of the Market
The refined glycerin market has emerged as an essential segment within the global chemicals and bio-based ingredients industry due to its versatility and compatibility with a wide range of applications. Refined glycerin, also known as glycerol, is a colorless, odorless, and sweet-tasting liquid derived mainly from vegetable oils and animal fats. It is widely used in pharmaceuticals, personal care, food and beverage, and industrial manufacturing because…
Plasmid DNA Manufacturing Market Analysis and Future Outlook Revealed by Persist …
The global plasmid DNA manufacturing market is undergoing a transformative expansion, with its value projected to grow from US$2.1 Bn in 2024 to US$7.0 Bn by 2031, reflecting a robust CAGR of 18.4%. According to Persistence Market Research, the surge is fueled by the rising demand for gene therapies, DNA vaccines, and advanced cell therapies that require plasmid DNA (pDNA) as a critical vector. Increasing incidences of genetic disorders and…
Assisted Reproductive Technology Market Trends and Insights Report by Persistenc …
The global assisted reproductive technology (ART) market is poised for strong expansion, with its valuation projected to reach US$58.5 Bn by 2031, growing at a CAGR of 9.2% between 2024 and 2031. This rapid rise is attributed to the increasing prevalence of infertility, advancements in in vitro fertilization (IVF) and related procedures, and wider societal acceptance of fertility treatments. According to Persistence Market Research, ART adoption is further encouraged by…
Lipid Nanoparticle Manufacturing Market Analysis and Forecast Report by Persiste …
The global lipid nanoparticle manufacturing market is witnessing remarkable momentum, driven by advancements in drug delivery technologies and expanding applications in RNA therapeutics. According to Persistence Market Research, the market was valued at US$814.2 million in 2023 and is projected to reach US$1.8 billion by 2031, registering a robust CAGR of 10.4% between 2024 and 2031. This growth reflects the rising demand for efficient delivery platforms for mRNA vaccines, gene…
More Releases for Uveitis
Uveitis Market : An Overview Report
Introduction:
Uveitis is an inflammatory condition affecting the uvea, the middle layer of the eye. It can lead to vision impairment or even blindness if left untreated. Uveitis is categorized into different types, including anterior, intermediate, posterior, and panuveitis, depending on the part of the eye affected. The condition can be caused by infections, autoimmune diseases, or trauma. With increasing cases of autoimmune disorders and infectious diseases, the prevalence of uveitis…
Uveitis Treatment Market Size, Share | Trend 2030
Exclusive Report by Ameco Research: Uveitis Treatment Market Size Projected to Reach USD 2 Billion by 2030, Growing at 6% CAGR
Ameco Research is proud to announce the launch of its latest market research report, Uveitis Treatment Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research…
Uveitis - Drug Pipeline Landscape, 2022
New York, Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of…
Uveitis - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of uveitis based…
Japan Industry Statistics of Uveitis Treatment
Global Uveitis Treatment Market: Overview
Uveitis, an autoimmune eye disease, is considered rare for just around 38 in 100,000 people are afflicted by it. Because of this, it is often overlooked. Patients afflicted by uveitis are often referred to an expert after much delay on account of less awareness about the eye malady. This delays timely diagnosis and results in irreversible damage to various ocular structures.
Read Report Overview: https://www.transparencymarketresearch.com/uveitis-treatment-market.html
As per Cochrane,…
Uveitis Treatment Market Analysis of Top industry Scenario
Global Uveitis Treatment Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).
According to a new report published by Allied Market Research, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy &…
